Texas Permanent School Fund bought a new position in Cantel Medical Corp. (NYSE:CMD) during the second quarter, Holdings Channel reports. The institutional investor bought 26,503 shares of the company’s stock, valued at approximately $2,065,000.

Other institutional investors have also recently made changes to their positions in the company. Integrated Investment Consultants LLC purchased a new position in shares of Cantel Medical Corp. during the second quarter worth approximately $161,000. LS Investment Advisors LLC purchased a new position in shares of Cantel Medical Corp. during the second quarter worth approximately $172,000. First Quadrant L P CA purchased a new position in shares of Cantel Medical Corp. during the second quarter worth approximately $233,000. Cue Financial Group Inc. purchased a new position in shares of Cantel Medical Corp. during the second quarter worth approximately $234,000. Finally, Bank of Montreal Can purchased a new position in shares of Cantel Medical Corp. during the second quarter worth approximately $248,000. Institutional investors and hedge funds own 83.88% of the company’s stock.

Cantel Medical Corp. (NYSE CMD) opened at 73.79 on Friday. Cantel Medical Corp. has a 12-month low of $68.19 and a 12-month high of $88.81. The stock’s 50 day moving average is $75.90 and its 200 day moving average is $76.88. The firm has a market cap of $3.06 billion, a P/E ratio of 43.66 and a beta of 1.23.

Cantel Medical Corp. (NYSE:CMD) last issued its earnings results on Thursday, June 8th. The company reported $0.51 earnings per share for the quarter, hitting the consensus estimate of $0.51. The business had revenue of $192.10 million for the quarter, compared to analyst estimates of $193.84 million. Cantel Medical Corp. had a return on equity of 17.75% and a net margin of 9.50%. The business’s revenue for the quarter was up 10.6% compared to the same quarter last year. On average, equities research analysts expect that Cantel Medical Corp. will post $2.06 EPS for the current year.

The company also recently declared a semiannual dividend, which was paid on Monday, July 31st. Shareholders of record on Monday, July 17th were given a dividend of $0.07 per share. This represents a yield of 0.18%. The ex-dividend date was Thursday, July 13th. Cantel Medical Corp.’s dividend payout ratio (DPR) is 8.28%.

COPYRIGHT VIOLATION WARNING: “Texas Permanent School Fund Invests $2.07 Million in Cantel Medical Corp. (NYSE:CMD)” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://www.dailypolitical.com/2017/08/12/texas-permanent-school-fund-invests-2-07-million-in-cantel-medical-corp-nysecmd.html.

A number of equities analysts have commented on the stock. Zacks Investment Research downgraded shares of Cantel Medical Corp. from a “hold” rating to a “sell” rating in a report on Monday, June 5th. Benchmark Co. downgraded shares of Cantel Medical Corp. from a “buy” rating to a “hold” rating in a report on Friday, June 9th. Needham & Company LLC restated a “hold” rating on shares of Cantel Medical Corp. in a report on Thursday, June 8th. Finally, Sidoti upgraded shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective on the stock in a report on Wednesday, August 2nd. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $91.67.

In other Cantel Medical Corp. news, Chairman Charles M. Diker sold 35,000 shares of Cantel Medical Corp. stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $75.52, for a total transaction of $2,643,200.00. Following the transaction, the chairman now owns 3,114,520 shares of the company’s stock, valued at $235,208,550.40. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Chairman Charles M. Diker sold 13,000 shares of Cantel Medical Corp. stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $76.36, for a total value of $992,680.00. Following the transaction, the chairman now directly owns 3,124,222 shares in the company, valued at approximately $238,565,591.92. The disclosure for this sale can be found here. Insiders own 14.90% of the company’s stock.

About Cantel Medical Corp.

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Want to see what other hedge funds are holding CMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cantel Medical Corp. (NYSE:CMD).

Institutional Ownership by Quarter for Cantel Medical Corp. (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.